Impacto del 18F-FDG PET/TC en el abordaje terapéutico del cáncer de pulmón no microcítico

Our data support previous reports that FDG-PET/CT is essential in the staging process not only for patients with potentially operable NSCLC but also for stage iii patients, as demonstrated by our data.